Novavax Inc (NVAX)
7.22
-0.54
(-7.02%)
USD |
NASDAQ |
Nov 14, 16:00
7.11
-0.11
(-1.52%)
After-Hours: 07:30
Novavax Net Income (TTM): -294.33M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -294.33M |
| March 31, 2024 | -398.71M |
| December 31, 2023 | -545.06M |
| September 30, 2023 | -548.92M |
| June 30, 2023 | -586.76M |
| March 31, 2023 | -1.155B |
| December 31, 2022 | -657.94M |
| September 30, 2022 | -1.322B |
| June 30, 2022 | -1.476B |
| March 31, 2022 | -1.318B |
| December 31, 2021 | -1.744B |
| September 30, 2021 | -1.075B |
| June 30, 2021 | -949.91M |
| March 31, 2021 | -615.11M |
| December 31, 2020 | -418.26M |
| September 30, 2020 | -272.52M |
| June 30, 2020 | -93.26M |
| March 31, 2020 | -115.34M |
| December 31, 2019 | -132.69M |
| September 30, 2019 | -150.20M |
| June 30, 2019 | -176.72M |
| March 31, 2019 | -181.61M |
| December 31, 2018 | -184.75M |
| September 30, 2018 | -186.26M |
| June 30, 2018 | -186.29M |
| Date | Value |
|---|---|
| March 31, 2018 | -186.27M |
| December 31, 2017 | -183.77M |
| September 30, 2017 | -190.04M |
| June 30, 2017 | -211.68M |
| March 31, 2017 | -246.57M |
| December 31, 2016 | -279.97M |
| September 30, 2016 | -301.66M |
| June 30, 2016 | -268.53M |
| March 31, 2016 | -209.82M |
| December 31, 2015 | -156.94M |
| September 30, 2015 | -109.68M |
| June 30, 2015 | -96.28M |
| March 31, 2015 | -93.51M |
| December 31, 2014 | -82.95M |
| September 30, 2014 | -65.46M |
| June 30, 2014 | -61.03M |
| March 31, 2014 | -55.80M |
| December 31, 2013 | -51.98M |
| September 30, 2013 | -45.96M |
| June 30, 2013 | -37.88M |
| March 31, 2013 | -31.17M |
| December 31, 2012 | -28.51M |
| September 30, 2012 | -24.18M |
| June 30, 2012 | -20.17M |
| March 31, 2012 | -19.25M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-1.744B
Minimum
Dec 2021
-93.26M
Maximum
Jun 2020
-722.01M
Average
-586.76M
Median
Jun 2023
Net Income (TTM) Benchmarks
| Pfizer Inc | 4.252B |
| Moderna Inc | -2.224B |
| Baxter International Inc | 108.00M |
| Inovio Pharmaceuticals Inc | -121.64M |
| AIM ImmunoTech Inc | -28.04M |